Billings Clinic
Especially For:

Clinical Trials

Title Start Date Principal Investigator (PI)
GYN GOG 0249 Endometrial Cancer: High Risk Early Stage Endometrial Cancer 08/14/2009  Randall Gibb, MD 
GYN Cancer: GOG 0235In Patients with Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer 08/14/2009  Randall Gibb, MD 
Prostate CTSU C70807 Observation 05/21/2012  Jorge Nieva, MD 
Amyloidosis In treated and Ineligible for Stem Cell Transplant 11/11/2011  Jorge Nieva, MD  
Asthma (AUSTRI) 03/15/2012  Kathleen Davis, MD 
Asthma - Pediatric 05/04/2012  Kathleen Davis, MD 
Bladder Ca:C90601 Advanced Transitional Cell Carcinoma 09/11/2009  Jorge Nieva, MD 
Bladder Cancer (RTOG 0524): Non-Cystectomy Candidates w Muscle Invasive Bladder Cancer 09/12/2008  John Schallenkamp, MD  
Bladder Cancer: S0337 Intravesical Gemcitabine in Patients with Superficial Bladder Cancer 12/08/2006  Jorge Nieva, MD 
Brain (N0577): Anaplastic Glioma, First Line 06/10/2011  Jorge Nieva, MD 
Brain (RTOG 0539): High Risk Meningiomas 01/08/2010  John Schallenkamp, MD 
Brain Cancer (N0574): Stereotactic Radiosurgery for One to Three Cerebral Metatases 11/10/2006  John Schallenkamp, MD 
Brain Cancer (N057K): Newly Dx Glioblastoma 03/12/2010  John Schallenkamp, MD 
Brain Cancer (RTOG R0834): Non-1P/19Q deleted Anaplastic Glioma 06/10/2011  John Schallenkamp, MD 
Brain Cancer: E3F05 Gliomas 11/13/2009  John Schallenkamp, MD 
Brain Metastasis (RTOG 0933) 05/13/2011  John Schallenkamp, MD 
Breast Cancer (RTOG 1005): Early Stage 06/10/2011  John Schallenkamp, MD 
Breast Cancer: Paritial Breast Irradiation SAVI 05/06/2008  John Schallenkamp, MD 
Breast Cancer: Adjuvant Chemotherapy HER2/Neu Positive Primary Breast Cancer 03/14/2008  Jorge Nieva, MD 
Breast Cancer: Breast Irradiation 03/11/2005  Jorge Nieva, MD 
Breast Cancer: NCCTG N1031 (North Central Cancer Treatment Group) 06/11/2010  Jorge Nieva, MD 
Breast, Recurrent (RTOG 1014): Repeat Surgery and Partial Breast Re-Irradiation 11/12/2010  John Schallenkamp, MD 
Breast: DCIS HER2+ 12/12/2008  Jorge Nieva, MD 
Carcinoid Tumors: Advanced with Poor Prognosis 01/11/2008  Jorge Nieva, MD 
Crohns 09/29/2013  Steven Hammond, MD 
CTSU 40601: Breast Cancer: Neoadjuvant HER2 Positive 01/09/2009  Jorge Nieva, MD 
CTSU CALGB 40601: Breast Cancer: HER2-Positive Primary Breast Cancer 01/09/2009  Jorge Nieva, MD 
CTSU SCISF0806 08/25/2011  Jorge Nieva, MD 
E2108: Early Local Therapy for Metastatic Breast Cancer 04/08/2011  Jorge Nieva, MD 
E3108: A Prospective Trial Correlating Progression Free Survival with CYP2D6 Activity in Patients with Metastatic Breast Cancer with Tamoxifen 11/12/2010  Jorge Nieva, MD 
GI (RTOG 0436): Esophagus Cancer Treated without Surgery 07/11/2008  John Schallenkamp, MD 
GI (RTOG 0848): Resected Head of Pancreas Treatment with Chemotherapy and Radiation 01/08/2010  John Schallenkamp, MD 
GI (RTOG 1010): HER2-Overexpressing Esophageal adenocarcinoma 03/11/2011  John Schallenkamp, MD 
GI Advanced Gallbladder Carcinoma or Cholangiocarcinoma 05/14/2010  Jorge Nieva, MD 
GI Cholangiocarcinoma 01/09/2009  Jorge Nieva, MD 
GI Neoadjuvant for Locally Advanced Esophagus, Gastroesophageal Junction, Gastric Cardia Cancer 03/12/2010  Jorge Nieva, MD 
GI Unresectable Hepatocelluar Carcinoma 12/11/2009  Jorge Nieva, MD 
GI- Colorectal Cancer Adjuvant 08/30/2010  Robert Geller, MD 
GI-Colorectal Cancer Metastatic-First Line 12/09/2005  Robert Geller, MD 
GI-Colorectal Metastatic Second Line 12/01/2010  Jorge Nieva, MD 
GI-First-Line Advanced Small Bowel Cancer 07/13/2007  Jorge Nieva, MD 
GI-Second Line Advanced Gastric or Gastroesophageal 02/11/2011  Jorge Nieva, MD 
GI: Metastatic Colorectal Cancer Potentially Resectable Liver Lesions 09/10/2010  Jorge Nieva, MD 
GI: Metastatic Esophageal, GE Junction, Gastric First Line 07/29/2011  Jorge Nieva, MD 
GI: Metastatic First Line Colorectal 08/25/2011  Jorge Nieva, MD 
GI: Metastatic Neuroendocrine Carcinoma of the Pancreas 12/10/2010  Jorge Nieva, MD 
GI: Stage I or II Colon Cancer Prevention Study 04/09/2010  Jorge Nieva, MD 
GOG 0241 Ovarian/Fallopian Tube/Primary Peritoneal Cancer: MUCINOUS EPITHELIAL OVARIAN OR FALLOPIAN TUBE CANCER 12/14/2010  Randall Gibb, MD 
GOG 0258 Endometrial Cancer: Endometrial Advanced Carcinoma, First Line 08/14/2009  Randall Gibb, MD 
GOG 0259 Peritoneal Cancer:Symptom Control 02/12/2010  Randall Gibb, MD 
GOG 0261 GYN newly dx Stage 1-4 persistent/recurrent uterine ca of ovary 11/01/2010  Randall Gibb, MD 
GOG 0262 Ovarain, Fallopian Tube, Peritoneal: Primary Stage 3-4 Epithelial Ovn/Peritoneal/Fallopian CA 12/08/2010  Randall Gibb, MD 
GOG-01861 Recurrent Ovarian, fallopian tube, primary peritoneal cancer 01/09/2012  Randall Gibb, MD 
GOG-0225 OVARIAN, FALLOPIAN TUBE AND PRIMARY PERITONEAL diet control 06/29/2012  Randall Gibb, MD 
GOG-0274 locally advanced cervical 06/06/2012  Randall Gibb, MD 
GU 90802 Renal Cell Carcinoma Advanced 11/10/2010  Jorge Nieva, MD 
GU: 9785-CL-0222 Abiaterone for mildly symptomatic 01/09/2012  Jorge Nieva, MD 
GU: S0931 Renal Cancer 05/26/2011  Jorge Nieva, MD 
GYN S0904 persistent, recurrent ovar/fallop tube/ primary peritoneal 11/01/2010  Randall Gibb, MD 
Head & Neck Cancer (RTOG 0920): Postoperative Radiation Therapy for Locally Advanced Resected 02/12/2010  John Schallenkamp, MD 
Head & Neck Recurrent and Metastatic 10/10/2008  Jorge Nieva, MD 
Head and Neck (RTOG 1016): HPV Associated Oropharynx Cancer 08/12/2011  John Schallenkamp, MD 
HerQles H4613g Solid Tumor Metastatic Locally Advanced Inoperable 09/03/2009  Jorge Nieva, MD 
Leukemia (C10403): Acute Lymphoblastic Leukemia with Adolscents and Young Adults. 02/08/2008  Jorge Nieva, MD 
Leukemia (C10404): Chronic Lymphocytic Leukemia Untreated 12/10/2010  Jorge Nieva, MD 
Leukemia (CA180330): Chronic Myeloid Leukemia Observational Study 09/26/2011  Brock Whittenberger, MD 
Leukemia (CC-5013-AML-001): Acute Myeloid Leukemia Not Previously Treated Age 65 and Older 04/25/2012  Jorge Nieva, MD 
Leukemia (E1908): Progressive Chronic Lymphocytic Leukemia Untreated 12/10/2010  Jorge Nieva, MD 
Leukemia (E2906): Newly Diagnosed Acute Myeloid Leukemia in Older Adults 04/08/2011  Jorge Nieva, MD 
Leukemia (S0535): Promyelocytic M3 12/14/2007  Jorge Nieva, MD 
Leukemia (S0805): Acute Lymphoblastic Leukemia (ALL) 09/01/2009  Jorge Nieva, MD 
Leukemia (S0919): Relapsed Acute Myeloid Leukemia 01/09/2009  Jorge Nieva, MD 
Leukemia (S1117) : CMML and Myelodysplastic Syndromes 06/08/2012  Jorge Nieva, MD 
Lung Cancer (RTOG 0937): Cranial Irradiation in Extensive Small Cell Lung Cancer 04/09/2010  John Schallenkamp, MD 
Lung Cancer: COX INHIBITOR COMPARISON 09/10/2010  Jorge Nieva, MD 
Lung Cancer: C30610 Limited Stage Small Cell Comparing Thoracic Radiation 05/09/2008  John Schallenkamp, MD 
Lung Cancer: CALGB 30607 Maintenance Therapy in Non progressing Patients following an Initial Four Cycles 02/12/2010  Jorge Nieva, MD 
Lung Cancer: Circulating Tumor Cells Stage IV, 2nd Line 02/15/2008  Jorge Nieva, MD 
Lung Cancer: CTSU 5508 Stage IIB or IV (1st or 2nd Line) 10/08/2010  Jorge Nieva, MD 
Lung Cancer: E1505 Completely Resected Stage 1B-IIIA 09/14/2007  Jorge Nieva, MD 
Lung Cancer: H3E-US-130 Cancer Stage IIIB or IV NSCLC 10/10/2009  Jorge Nieva, MD 
Lung Cancer: N0923 Extensive Stage Small Cell Lung after Standard Treatment with Platinum Based Chemotherapy 02/12/2010  Jorge Nieva, MD 
Lung Cancer: S0709 Advanced NSCLC Stage IIIB or IV, First Line   Jorge Nieva, MD 
Lung Cancer: S0802 Platinum Treated Extensive Small Cell Lung Cancer 06/12/2009  Jorge Nieva, MD 
Lung Cancer: Stage IV or Recurrent NSCLC 08/14/2009  Jorge Nieva, MD 
Lung Cancer: Stage IV, 2nd line 02/01/2011  Jorge Nieva, MD 
Lymphoma (C50604): Non-Bulky Stage I and II Hodgkin's 09/10/2010  Jorge Nieva, MD 
Lymphoma (C50904): Follicular Lymphoma Untreated 06/08/2012  Jorge Nieva, MD 
Lymphoma (CALGB 50303): Non-Hodgkins Large B Cell 07/08/2004  Jorge Nieva, MD 
Lymphoma (E1411): Newly Diagnosed Mantle Cell 07/17/2012  Jorge Nieva, MD 
Lymphoma (S0806): Advanced Stage Diffuse Large B Cell 12/10/2010  Jorge Nieva, MD 
Lymphoma (S0816): Hodgkin's Stage III - IV 08/14/2009  Jorge Nieva, MD 
Lymphoma (S1001): Limited Stage Diffuse Large B Cell 09/09/2011  Jorge Nieva, MD 
Lymphoma (S1108): Peripheral T-cell Relapsed/Refractory 12/14/2011  Jorge Nieva, MD 
Melanoma E1609 05/21/2012  Jorge Nieva, MD 
Melanoma E2607 05/21/2012  Jorge Nieva, MD 
Melanoma: E1609 First line 08/12/2011  Jorge Nieva, MD 
Melanoma: N0879 metastatic Stage II-III post wide excision 02/01/2011  Jorge Nieva, MD 
Melanoma:M101b' Ziopharm Stage III-IV MALIGNANT UNRESECTABLE 08/06/2010  Jorge Nieva, MD 
Merck V212-011 01/06/2012  Jorge Nieva, MD 
Multiple Myeloma (DMAB): Newly Diagnosed Multiple Myeloma with Bone Disease 06/12/2012  Brock Whittenberger, MD 
Multiple Myeloma (E3A06): Hi-Risk Smoldering Myeloma 12/10/2010  Jorge Nieva, MD 
Multiple Myeloma (MMRF): Observational Study in Newly Diagnosed 10/18/2011  Brock Whittenberger, MD 
Multiple Myeloma: Prev Untreated MM w or wo SCT 05/09/2009  Jorge Nieva, MD 
Myelodysplastic Syndrome (E2905) Low or Intermediate Risk 03/13/2009  Jorge Nieva, MD 
N0871 Unknown Primary 11/13/2009  Jorge Nieva, MD 
N0872 recurrent Gliioblastoma 05/21/2012  Jorge Nieva, MD 
NSABP B-47: A Randomized Trial Comparing Chemotherapy Alone to Cheotherapy + Trasztuzumab 02/11/2011  Jorge Nieva, MD 
NSABP B43: Trastuzumab + Radiation or Radiation Alone for HER2+ DCIS 12/28/2008  John Schallenkamp, MD 
NSABP Protocol DMP-1 08/25/2011  Jorge Nieva, MD 
Pacemaker 09/26/2013  Loren Budge, MD 
PaceMaker 09/23/2013  Loren Budge, MD 
Prostate Cancer (RTOG 0534) w Rising PSA after Radical Prostatectomy 01/11/2008  John Schallenkamp, MD 
Prostate Cancer (RTOG 0622): Irradiation for High Risk Clinically Non-Metastatic Prostate Cancer After Prostatectomy 05/08/2009  John Schallenkamp, MD  
Prostate Cancer (RTOG 0815): Radiotherapy with or without Short Term Androgen Deprivaiton Therapy 02/12/2010  John Schallenkamp, MD  
Prostate Cancer (RTOG 0924): Androgen Deprivation and High dose Radiation Therapy With or Without Whole Pelvic Radiation 10/15/2012  John Schallenkamp, MD 
Prostate Cancer (RTOG 0938): Hypofractionated Radiation treatment for Favorable Risk Prostate Cancer 09/17/2012  John Schallenkamp, MD 
Prostate Cancer: CALGB 90202 with Bone Metastates Prevention of Skeletal Related Events 03/12/2004  Jorge Nieva, MD 
Prostate Cancer: CALGB 90203 Prior to Prostatectomy 02/09/2007  Jorge Nieva, MD 
Prostate Cancer: CTSU PR11 favorable risk prostate cancer 06/11/2010  Jorge Nieva, MD 
Prostate Cancer: S0925 Hormone-Sensitive Metastatic Prostate Ca 02/11/2011  Jorge Nieva, MD 
Prostate Cancer:E3805 Extensive Disease 09/08/2006  Jorge Nieva, MD 
Prostate: S1014 Metastatic, First Line 08/15/2011  Jorge Nieva, MD 
Spine (RTOG 0631): Localized Metastasis 02/12/2010  John Schallenkamp, MD 
SWOG S0500: Breast Cancer: Metastatic First Line Circulating Tumor Cells 11/10/2006  Jorge Nieva, MD 
SWOG S0800: Breast Cancer Neoadjuvant Inflammatory and Locally Advanced Her-2 Neu Negative 11/13/2009  Jorge Nieva, MD 
SWOG S1007: Standard Adjuvant Chemotherapy in High-Risk Patients with Oncotype Recurrence Score of 25 or Less 02/11/2011  Jorge Nieva, MD 
SWOG- S0905 Mesotheilioma 05/21/2012  Jorge Nieva, MD 
Symptom Management Cancer Related Fatigue 11/13/2009  Jorge Nieva, MD 
Symptom Management Hot Flashes with Prostate Cancer 09/11/2009  Jorge Nieva, MD 
Symptom Management Metastatic Cancer Receiving Zoledronic Acid 05/08/2009  Jorge Nieva, MD 
Symptom Management Nausea and Vomiting with Radiation Therapy 01/08/2010  Jorge Nieva, MD 
Symptom Management Paclitaxel Associated Pain 04/10/2009  Jorge Nieva, MD 
Symptom Management Patient Receiving Treatment for Bone Metastases 01/09/2009  Jorge Nieva, MD 
Symptom Management Taxane Induced Neuropathy 06/12/2009  Jorge Nieva, MD 
Symptom Managment (RTOG 1012): Manuka Honey to Treat Esophagitis-Related Pain During Lung Cancer Treatment 08/13/2012  John Schallenkamp, MD 
Type 1 Diabetes (ADJUNCT 1) 09/26/2013  Christopher Sorli, MD 
Type 2 Diabetes (BCB109) 12/28/2010  Christopher Sorli, MD 
Type 2 Diabetes (DEVOTE) 09/26/2013  Christopher Sorli, MD 
Type 2 Diabetes (ITCA 105) 05/28/2013  Christopher Sorli, MD 
Type 2 Diabetes (ITCA 107) 05/28/2013  Christopher Sorli, MD 
Type 2 Diabetes (SUSTAIN 1) 09/26/2013  Christopher Sorli, MD 
Type 2 Diabetes - EndoBarrier, The ENDO trial 12/24/2012  James Mack, MD 
Unterine Corpus Cancer: Stage 1-3 02/11/2011  Randall Gibb, MD 
Z1071: A Phase II Study Evaluating Lymph Node Positive Cancers   Jorge Nieva, MD 
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.